Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
09/23/2014 | US8840897 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (NAIT) |
09/23/2014 | US8840896 Anti-HER2 antibody variants |
09/23/2014 | US8840895 Human antibodies specifically binding to the hepatitis B virus surface antigen |
09/23/2014 | US8840894 Antibodies to human GDF8 |
09/23/2014 | US8840893 Methods for treating conditions associated with MASP-2 dependent complement activation |
09/23/2014 | US8840892 Method of administering antibiotic therapy for treating intracellular infectious diseases |
09/23/2014 | US8840891 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
09/23/2014 | US8840890 Rapid expression cloning of human monoclonal antibodies from memory B cells |
09/23/2014 | US8840889 Methods of modulating immune function |
09/23/2014 | US8840888 Dosage regimen for administering a CD19XCD3 bispecific antibody |
09/23/2014 | US8840887 Antibodies |
09/23/2014 | US8840886 Method of treating cancer with DLL4 antagonist and chemotherapeutic agent |
09/23/2014 | US8840885 Methods for treating chronic lymphocytic leukemia |
09/23/2014 | US8840884 Antibody-containing solution pharmaceuticals |
09/23/2014 | US8840881 Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer |
09/23/2014 | US8840877 Polysaccharide-protein conjugates reversibly coupled via imine bonds |
09/23/2014 | CA2725390C Use of a hdac inhibitor and a her-2 inhibitor in the treatment of breast cancer |
09/23/2014 | CA2691357C Antibodies to human programmed death receptor pd-1 |
09/23/2014 | CA2683009C Use of il-18 inhibitors |
09/23/2014 | CA2666308C Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
09/23/2014 | CA2646934C Methods for reducing protein aggregation |
09/23/2014 | CA2638902C Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1 antibodies |
09/23/2014 | CA2599831C Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter |
09/23/2014 | CA2588908C Induction of neurogenesis and stem cell therapy in combination with copolymer 1 |
09/23/2014 | CA2548990C Toll-like receptor 4 (tlr4)-neutralizing antibodies |
09/23/2014 | CA2525975C Humanized antibodies that recognize beta amyloid peptide |
09/23/2014 | CA2520271C Methods for the diagnosis and treatment of epilepsy |
09/23/2014 | CA2490758C Dosage form of recombinant humanized monoclonal antibody 2c4 |
09/23/2014 | CA2490218C Extracorporeal photopheresis in combination with anti-tnf treatment |
09/23/2014 | CA2473039C Novel anti-igf-ir antibodies and uses thereof |
09/23/2014 | CA2467781C Use of a monoclonal antibody specific for a red blood cell to inhibit the reticuloendothelial system for the treatment of thrombocytopenia |
09/23/2014 | CA2378182C Compositions and methods for the treatment of tumors |
09/18/2014 | WO2014145968A2 Rna interference functions as an antiviral immunity in mammals |
09/18/2014 | WO2014145958A2 Network-based microbial compositions and methods |
09/18/2014 | WO2014145951A2 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom |
09/18/2014 | WO2014145932A2 Specific multivalent virus-like particle vaccines and uses thereof |
09/18/2014 | WO2014145907A1 Targeting t cells with heterodimeric proteins |
09/18/2014 | WO2014145843A2 Methods for treating cancer |
09/18/2014 | WO2014145797A2 Method for treating eclampsia and preeclampsia |
09/18/2014 | WO2014145722A2 Cooperative photography |
09/18/2014 | WO2014145683A1 Diabetes treatment |
09/18/2014 | WO2014145642A2 Nrf2 small molecule inhibitors for cancer therapy |
09/18/2014 | WO2014145631A1 Dendritic cell response gene expression, compositions of matters and methods of use thereof |
09/18/2014 | WO2014145524A2 Compositions and methods for immune tolerance induction to factor viii replacement therapies in subjects with hemophilia a |
09/18/2014 | WO2014145408A1 Clinical methods for determining hiv-1 receptor tropism and cellular reservoirs of hiv-1 replication |
09/18/2014 | WO2014145355A1 Composition comprised of antigen linked to a tnf superfamily ligand |
09/18/2014 | WO2014145302A2 Synthesis of ent-progesterone and intermediates thereof |
09/18/2014 | WO2014145287A2 Swine influenza viruses and constructs and uses thereof |
09/18/2014 | WO2014145174A1 Immunogenic human rhinovirus (hrv) compositions |
09/18/2014 | WO2014145091A1 Cell culture media and methods of antibody production |
09/18/2014 | WO2014145038A1 Vaccines with biomolecular adjuvants |
09/18/2014 | WO2014144965A1 Attenuated salmonella bacteria and methods of using |
09/18/2014 | WO2014144885A2 Cancer vaccines and methods of treatment using the same |
09/18/2014 | WO2014144850A1 Methods of treating cancer and preventing cancer drug resistance |
09/18/2014 | WO2014144836A2 Carbamate derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors |
09/18/2014 | WO2014144804A1 Biomarkers for radiation treatment |
09/18/2014 | WO2014144775A2 Rodent hepadnavirus cores with reduced carrier-specific antigenicity |
09/18/2014 | WO2014144763A2 High affinity anti-gd2 antibodies |
09/18/2014 | WO2014144756A1 Palivizumab epitope-based virus-like particles |
09/18/2014 | WO2014144725A2 Melatonin monoclonal antibody, detection, methods and uses thereof |
09/18/2014 | WO2014144600A2 Multivalent and monovalent multispecific complexes and their uses |
09/18/2014 | WO2014144594A1 Toxoid, compositions and related methods |
09/18/2014 | WO2014144573A2 Multimerization technologies |
09/18/2014 | WO2014144567A2 Toxoid, compositions and related methods |
09/18/2014 | WO2014144553A1 Secreted frizzle-related protein 5 (sfrp5) binding proteins and methods of treatment |
09/18/2014 | WO2014144549A1 Factor ix polypeptide formulations |
09/18/2014 | WO2014144542A2 Methods of generating bioactive peptide-bearing antibodies and compositions comprising the same |
09/18/2014 | WO2014144292A2 Antibodies against clostridium difficile toxins and methods of using the same |
09/18/2014 | WO2014144222A2 Compositions and methods of treating fungal and bacterial pathogens |
09/18/2014 | WO2014144211A2 Compositions and methods for treating fungal and bacterial pathogens |
09/18/2014 | WO2014144153A2 Metapneumovirus immunogens and related materials and methods |
09/18/2014 | WO2014144095A2 Compositions comprising d-amino acid peptides and methods of production and use thereof for inhibiting autoantibodies |
09/18/2014 | WO2014144024A1 Hyr1 compositions and methods for treating fungal and bacterial pathogens |
09/18/2014 | WO2014143909A1 Anti-prolactin receptor antibody formulations |
09/18/2014 | WO2014143886A2 Anti-ectodysplasin antibodies |
09/18/2014 | WO2014143835A1 Combination/adjuvant therapy for wt-1-positive disease |
09/18/2014 | WO2014143815A2 Drug cassette, autoinjector, and autoinjector system |
09/18/2014 | WO2014143807A2 Anti-cd37 antibody and bcr pathway antagonist combination therapy for treatment of b-cell malignancies and disorders |
09/18/2014 | WO2014143781A1 Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities |
09/18/2014 | WO2014143739A2 Anti-alpha v beta 6 antibodies and uses thereof |
09/18/2014 | WO2014143622A1 ACTIVATED CARBON FILTRATION FOR PURIFICATION OF BENZODIAZEPINE ADCs |
09/18/2014 | WO2014143540A1 Methods for treating crohn's disease using an anti-il23 antibody |
09/18/2014 | WO2014143343A1 Hcv core lipid binding domain monoclonal antibodies |
09/18/2014 | WO2014143342A1 Hcv ns3 recombinant antigens and mutants thereof for improved antibody detection |
09/18/2014 | WO2014143205A1 Human antibodies that bind human tnf-alpha and methods of preparing the same |
09/18/2014 | WO2014143185A1 Purification of proteins using hydrophobic interaction chromatography |
09/18/2014 | WO2014143087A1 Peptide vaccine for prevention and immunotherapy of dementia of the alzheimer's type |
09/18/2014 | WO2014142515A1 Porcine circovirus (pcv2) subunit vaccine using recombinant yeast whole cells and method for manufacturing same |
09/18/2014 | WO2014142356A1 Therapeutic agent for scleroderma |
09/18/2014 | WO2014142220A1 Anti-tumor agent |
09/18/2014 | WO2014142182A1 Monoclonal antibody inhibiting enzymatic activity of endothelial lipase |
09/18/2014 | WO2014142117A1 Anti-staphylococcus antibody, method for manufacturing same, and usage of same |
09/18/2014 | WO2014142084A1 METHOD FOR PRODUCING MONOCLONAL IgA ANTIBODY |
09/18/2014 | WO2014141683A1 Kntc2 peptides and vaccines containing the same |
09/18/2014 | WO2014141271A1 Use of anti-eotaxin antibodies for treating inflammatory bowel disease |
09/18/2014 | WO2014141176A1 Improved poxviral vaccines |
09/18/2014 | WO2014141152A2 Low concentration antibody formulations |
09/18/2014 | WO2014141149A1 Formulations with reduced viscosity |
09/18/2014 | WO2014141145A1 Modified molecules resistant to proteolytic degradation |
09/18/2014 | WO2014141125A2 Influenza virus reassortment |